Pricing

Latest News

With the Rise of GLP-1 Agonists for Treating Obesity, Will Access Challenges Prevent Progress?
With the Rise of GLP-1 Agonists for Treating Obesity, Will Access Challenges Prevent Progress?

March 1st 2024

JAMA commentary suggests that issues such as high costs, access, and equity will stop patients from obtaining GLP-1 agonists to treat obesity.

Biosimilars Report Shows Challenges, Opportunities Across Disease States
Biosimilars Report Shows Challenges, Opportunities Across Disease States

February 29th 2024

Image credit: driftwood | stock.adobe.com. copay text on calculator with money and prescription pills in bottle
Copay Adjustment Programs: What’s Next for Manufacturers?

February 19th 2024

Philipp Hofmann, MD
Current Status of Biosimilars and Their Impact on Pharmacovigilance

February 7th 2024

Report: Insulin Prices in US Substantially Higher than Other Countries
Report: Insulin Prices in US Substantially Higher than Other Countries

February 5th 2024

More News